Fig. 1From: Peritoneal cell-free DNA as a sensitive biomarker for detection of peritoneal metastasis in colorectal cancer: a prospective diagnostic studyThe workflow of patient enrollment in this study. 40 CRC patients were including in the training cohort underwent NGS assays for mutational profiles of peritoneal cfDNA and 11 CRC patients were enrolled in the validation cohortBack to article page